Person

Elizabeth G. Nabel

Director, Moderna

Current S&P 500 boards
2
Current roles
2
Open-market buys
$0
Open-market sales
$8.5M

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

None on record since 2016.

Sits alongside

People who currently share a board or management team with this person.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
Jul 15, 2020MRNASale73,975$87.84$6.5M
May 12, 2020MRNASale30,000$66.00$2.0M

SEC reporting-owner ID (CIK) 1619929 · all filings on EDGAR

Elizabeth G. Nabel (MRNA, MDT) | USBoard